| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Odyssey Health, Inc. last filed a Form 4 in June 2025, as 10% Owner at OGEN.
Odyssey Health, Inc. has 2 Form 4 filings on record in June 2025, all as 10% Owner at Oragenics (OGEN), 2025.
The 4 reported transactions were 4 open-market sales.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $74K.
The largest open-market sale was 10,000 shares of OGEN at an average $4.36 on June 16, 2025, about $44K.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.